Abstract:Sixteen Co(II), Ni(II), Cu(II) and Zn(II) complexes were synthesized by four Schiff base ligands 4-((4-(benzyloxy)-2-hydroxybenzylidene)amino)-[1,1'-biphenyl]-3-ol (H2L1), 6-((4-(benzyloxy)-2-hydroxybenzylidene)amino)-4,6-dichloro-3-methylphenol (H2L2), 2-((4-(benzyloxy)-2-hydroxybenzylidene)amino)-6-chloro-4-nitrophenol (H2L3), 5-(benzyloxy)-2-(((2-hydroxyphenyl)imino)methyl)phenol (H2L4) obtained from condensation reaction of 4-(benzyloxy)-2-hydroxybenzaldehyde with various aminophenol derivatives and well characterized by various spectroscopic techniques (FT-IR, UV–Vis, NMR, ESR, SEM, fluorescence), mass spectrometry, elemental analysis (CHN) and physical studies (TGA, XRD, molar conductance, melting point). The various characterization data suggested that the Schiff base ligands coordinated via nitrogen of azomethine and deprotonated phenolic oxygen atoms (ONO) with metal ions in 1:1 molar ratio having general formula [M(L1−4)(H2O)2(CH3COO)]. Low values of molar conductance of compounds suggested their non-electrolytic nature. The thermal decomposition of complexes indicated that metal complexes are stable up to 150 °C and give metal oxide as end product. Using SEM analysis, the surface morphology of the synthesized compound was determined. The compounds (1–20) were evaluated for their in vitro antioxidant activity and found that the synthesized metal(II) complexes are highly potent and also show good efficiency for decolourizing the purple-coloured solution of DPPH compared to free Schiff base ligands and Cu(II) complexes were most potent having IC50 value from 2.98 to 3.89 µM range. The compounds (1–20) were assayed for their in vitro antimicrobial activities against four bacterial strains (S. aureus, B. subtilis, P. aeruginosa, E. coli) and two fungal strains (A. niger, C. albicans) by serial dilution method, and it was found that the metal(II) complexes are more noxious than free Schiff base ligands. The antimicrobial activity results showed that the complexes 10, 11, 14 and 15 were most active compounds. Antifungal activity of complex 11 (Cu(L2)(CH3COO)(H2O) against C. albicans was found to be comparable to standard drug. The molecular docking of ligand H2L2 (2) and its Cu(II) complex (11) with enzyme C. albicans sterol 14-alpha demethylase suggested the hydrophobic binding. Furthermore, in silico study stressed that the compounds may be used as orally active drugs.Graphical abstractThe synthesized compounds (1–20) were screened for in vitro antimicrobial activity. Copper complex (11) was found to be the most potent antimicrobial agent and which is held by hydrophobic interactions in the active site of the enzyme C. albicans sterol 14-alpha demethylase.

Synthesis, characterization, molecular modeling, and antimicrobial study of copper(II) 2-chlorophenylacetohydroxamate

Synthesis, Crystal Structures, Photophysical Properties and Antibacterial Activities of Copper(II) Complex Derived from 4-Chloro-2-{[(2,6-dimethylphenyl)imino]methyl}phenol

Synthesis, characterization and antibacterial test of Tetrakis(3-Aminophenol) Copper(II)Nitrate Hexahydrate

Investigation of the inherent characteristics of copper(II) Schiff base complexes as antimicrobial agents

Synthesis, Characterization, Crystal Structure and Antimicrobial Activity of Copper(II) Complexes with the Schiff Base Derived from 2-Hydroxy-4-Methoxybenzaldehyde

Synthesis, Characterization, and Antibacterial Evaluation of Copper(ii) Complexes Supported by Phenylacetic Acid Derivatives, and Diamine Ligands

SYNTHESIS, CHARACTERIZATION OF COPPER(II) COMPLEX WITH TETRADENTATE N2O2 AND POTENTIAL CONTRIBUTION AS PROMISING ANTIBACTERIAL STUDIES

SYNTHESIS, CHARACTRIZATION AND ANTIBACTERIAL ACTIVITY OF SCHIFF BASES DERIVED FROM PHENYL HYDRAZINE DERIVATIVES AND THEIR Cu (II) and Zn (II) COMPLEXES

Synthesis, Characterization, Antibacterial and Thermal Studies of Cu(II) Complex of Thiophene-2- aldehyde Semicarbazone

Synthesis, Structural Characterization, in Vitro Biological Activity, and Computational Quantum Chemical Studies of New Cobalt (II), Nickel (II), and Copper (II) Complexes Based on an Azo-Azomethine Ligand

Synergistic Effects of Steric Constraints and Non-covalent Interactions in Copper(II) Chloro-Nitro-Benzoato Complexes: Synthesis, Structural Characterization, Theoretical Investigations, Antimicrobial Studies, and Molecular Docking Analyses

Synthesis and characterisation of phenanthroline-oxazine ligands and their Ag(I), Mn(II) and Cu(II) complexes and their evaluation as antibacterial agents

Synthesis, characterization, antimicrobial activity and molecular docking study of transition metal complexes based on azo coumarin and thiosemicarbazone derivative

Synthesis, Characterization, DNA Cleavage, and Antimicrobial Studies of Some Transition Metal Complexes With a Novel Schiff Base Derived From 2-Aminopyrimidine

Synthesis, characterization and antimicrobial study of polymeric transition metal complexes of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II)

Synthesis, characterization and antibacterial activity of copper(ii) and nickel(ii) complexes with 3, 10-dialkyl-1, 3, 5, 8, 10, 12 hexaazacyclotetradecane ligand

Investigation of biological activity of oxindole semicarbazones based copper (II) complexes: Synthesis, antimicrobial activities and molecular modelling

Synthesis, structural analysis, in vitro antioxidant, antimicrobial activity and molecular docking studies of transition metal complexes derived from Schiff base ligands of 4-(benzyloxy)-2-hydroxybenzaldehyde

Synthesis, spectro-themal characterization, DFT calculations and biochemical evaluation of a newly synthesized tridentate Schiff base transition metal complexes

Syntheses, characterizations, crystal structures, antibacterial and SOD-like activities of nickel(II) and copper(II) complexes with 2-((Z)-(4-methoxyphenylimino)methyl)-4,6-dichlorophenol

Synthesis and characterization of novel metal complexes with new azo-schiff base ligand derived from sulfa drug and toxicological studies of its complexes as antibacterial